These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11899392)

  • 1. Magnetic resonance imaging of occult breast cancer.
    Baker DR
    Clin Breast Cancer; 2000 Apr; 1(1):66-7. PubMed ID: 11899392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women.
    Wright H; Listinsky J; Rim A; Chellman-Jeffers M; Patrick R; Rybicki L; Kim J; Crowe J
    Am J Surg; 2005 Oct; 190(4):572-5. PubMed ID: 16164923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
    Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
    Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation.
    Kühr M; Wolfgarten M; Stölzle M; Leutner C; Höller T; Schrading S; Kuhl C; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e541-6. PubMed ID: 21664064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
    Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
    Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
    Lee CH; Dershaw DD; Kopans D; Evans P; Monsees B; Monticciolo D; Brenner RJ; Bassett L; Berg W; Feig S; Hendrick E; Mendelson E; D'Orsi C; Sickles E; Burhenne LW
    J Am Coll Radiol; 2010 Jan; 7(1):18-27. PubMed ID: 20129267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience.
    Bernard JR; Vallow LA; DePeri ER; McNeil RB; Feigel DG; Amar S; Buskirk SJ; Perez EA
    Breast J; 2010; 16(2):118-26. PubMed ID: 20136645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.
    de Bresser J; de Vos B; van der Ent F; Hulsewé K
    Eur J Surg Oncol; 2010 Feb; 36(2):114-9. PubMed ID: 19822403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
    Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI
    Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New methods for minimal invasive assessment of uncertain mammography and MRI tomography findings].
    Heywang-Köbrunner SH; Smolny T; Schaumlöffel U; Heinig A; Buchmann J; Lampe D
    Zentralbl Chir; 1998; 123 Suppl 5():66-9. PubMed ID: 10063577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: the role of breast magnetic resonance imaging for staging.
    Chen C; Orel SG; Schnall MD; Harris E; Solin LJ
    Clin Breast Cancer; 2002 Aug; 3(3):219-22. PubMed ID: 12196282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MRI for breast disease diagnosis; an asset, but the proper place has to be determined first].
    Wobbes T
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1490-2. PubMed ID: 16032991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for breast MRI: case-based review.
    Argus A; Mahoney MC
    AJR Am J Roentgenol; 2011 Mar; 196(3 Suppl):WS1-14. PubMed ID: 21343536
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma.
    Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M
    Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI in patients with axillary metastases of occult breast carcinoma.
    Tilanus-Linthorst MM; Obdeijn AI; Bontenbal M; Oudkerk M
    Breast Cancer Res Treat; 1997 Jun; 44(2):179-82. PubMed ID: 9232276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
    Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
    Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.